1. Cost Impact of a Pharmacist-Driven Medication Reconciliation Program during Transitions to Long-Term Care and Retirement Homes.
- Author
-
O'Donnell D, Beaton C, Liang J, Basu K, Hum M, Propp A, Yanni L, Chen Y, and Ghafari P
- Subjects
- Drug-Related Side Effects and Adverse Reactions prevention & control, Homes for the Aged, Hospitalization economics, Humans, Long-Term Care, Ontario, Pharmaceutical Preparations economics, Pharmacists, Polypharmacy, Retrospective Studies, Cost Savings, Medication Reconciliation economics
- Abstract
The current provincial funding model in Ontario, Canada, does not offer dedicated funding to drive medication reconciliation (MedRec) programs during transitions into long-term care and retirement homes. This economic analysis aimed to estimate potential cost savings attributed to hospitalizations averted and decreases in polypharmacy by a MedRec program from a healthcare payer perspective. From a pool of 6,678 pharmacist recommendations, a limited sample of recommendations targeting specific medication-related adverse events showed potential savings of $622.35 per patient from hospital admissions avoided and of $1,414.52 per patient per year from medication discontinuations. Pharmacist-driven MedRec, conducted virtually, delivers substantial healthcare savings., (Copyright © 2020 Longwoods Publishing.)
- Published
- 2020
- Full Text
- View/download PDF